Carla Fiankan

Carla Fiankan is Adverum’s senior vice president of regulatory affairs. In her role, Ms. Fiankan develops and manages the regulatory strategies for Adverum’s suite of gene therapy products and oversees all facets of Adverum’s global regulatory affairs, including filings and interactions with the major regulatory authorities around the world. Throughout her 27-year career, Ms. Fiankan has led global regulatory strategies for the development, licensure, and life-cycle management of biologics, pharmaceuticals, medical devices, and gene therapy products and has successfully developed, managed, and executed strategies to meet board-led targets and corporate objectives.

Ms. Fiankan earned her bachelor of science degree in biology from Notre Dame de Namur University and her master of science in microbiology from San Jose State University.